Anterior Temporal Lobectomy

Subscribe to Selected New Research on Anterior Temporal Lobectomy

289 relevant articles (7 outcomes, 36 trials/studies) found for this Therapy

Description: A neurosurgical procedure that removes the anterior TEMPORAL LOBE including the medial temporal structures of CEREBRAL CORTEX; AMYGDALA; HIPPOCAMPUS; and the adjacent PARAHIPPOCAMPAL GYRUS. This procedure is generally used for the treatment of intractable temporal epilepsy (EPILEPSY, TEMPORAL LOBE).

Also Known As:

Lobectomy, Anterior Temporal

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Neurosurgical Procedures: 580

Anterior Temporal Lobectomy: 289

Experts

1.	Cascino, Gregory D: 3 articles (09/2003 - 01/2002)
2.	Marsh, W Richard: 2 articles (09/2003 - 01/2003)
3.	Baulac, M: 1 article (03/2008)
4.	Dupont, S: 1 article (03/2008)
5.	Samson, S: 1 article (03/2008)
6.	Lee, Ji-Young: 1 article (01/2008)
7.	Lee, Seo-Young: 1 article (01/2008)
8.	Lee, Sang Kun: 1 article (01/2008)
9.	Kim, Dong Wook: 1 article (01/2008)
10.	Chung, Chun Kee: 1 article (01/2008)

Related Diseases

1.	Seizures (Seizure) 03/01/2005 - "Complete seizure remission after successful anterior temporal lobectomy enables some active duty military members to continue service in the U.S" 05/01/2000 - "CONTEXT: Anterior temporal lobectomy is an effective treatment for medically intractable temporal lobe seizures" 01/01/2002 - "After left anterior temporal lobectomy with hippocampectomy, seizure control was improved" 10/01/1996 - "PURPOSE: We assessed test-retest neuropsychological performance in patients with complex partial seizures to derive reliable change indices (RCIs) and regression-based norms for change, indices that may be helpful in assessing cognitive outcome after anterior temporal lobectomy" 01/01/1984 - "Reexamination of 23 patients 1 year after elective anterior temporal lobectomy for intractable complex partial (psychomotor) seizures showed a reduction in certain memory functions combined with an improvement in others" Get all the results and reference details, order at left...
2.	Temporal Lobe Epilepsy 11/01/2006 - "PURPOSE: Although anterior temporal lobectomy (ATL) is an effective treatment for many patients with medically refractory temporal lobe epilepsy (TLE), one risk associated with this procedure is postsurgical decline in memory" 08/01/2005 - "The aim of the present study was to evaluate the psychiatric status, quality of life, and level of disability in medically refractory mesial temporal lobe epilepsy (MTLE) patients, a homogenous subgroup of patients with TLE, before and after anterior temporal lobectomy (ATL)" 08/01/2000 - "The study involved 14 patients with temporal lobe epilepsy ultimately treated by anterior temporal lobectomy" 08/01/1999 - "CONCLUSIONS: It appears that specific types of localization-related temporal lobe epilepsy are more closely associated with the risk of adverse language outcome after anterior temporal lobectomy than with the surgical variations investigated in this study." 06/01/2008 - "The sample consisted of all patients with a primary diagnosis of medically intractable temporal lobe epilepsy (TLE) who underwent anterior temporal lobectomy" Get all the results and reference details, order at left...
3.	Myoclonus (Nocturnal Myoclonus) 04/01/2001 - "The unusual case of newly-emerged bilateral myoclonus in a 39-year-old man following anterior temporal lobectomy, which cured his temporal lobe epilepsy, is reported" 04/01/2001 - "Postoperative myoclonus simulating seizure recurrence: a rare complication of anterior temporal lobectomy." Get all the results and reference details, order at left...
4.	Epilepsy (Aura) 09/20/2006 - "In our study we analyzed retrospectively the possible electro-clinical, neuroimaging and surgery-related outcome predictors in 94 adult patients who had anterior temporal lobectomy (ATL) from the material of Epilepsy Centre of the National Institute of Psychiatry and Neurology, Budapest since the beginning of the surgery program in 1989 until 2001" 02/01/2004 - "PURPOSE: The goal of this study was to assess the patient-perceived costs and benefits associated with the longer-term outcomes of epilepsy surgery in patients who underwent anterior temporal lobectomy or selective amygdalohippocampectomy" 02/01/1999 - "The aim of this study was to examine factors precipitating patient readmission, following anterior temporal lobectomy (ATL) for refractory epilepsy" 08/01/1998 - "Predictors of outcome of anterior temporal lobectomy for intractable epilepsy: a multivariate study." 07/01/1994 - "This study investigated postoperative language outcome in our entire series (n = 162) of nonretarded, left hemisphere speech dominant patients with intractable nonlesional epilepsy who underwent a left (n = 85) or right (n = 77) anterior temporal lobectomy without functional mapping" Get all the results and reference details, order at left...
5.	Sclerosis 05/01/2005 - "PURPOSE: Previous studies have shown that structural integrity (i.e., presence/absence of mesial temporal sclerosis (MTS)) of the left mesial temporal lobe is associated with verbal memory outcome following left anterior temporal lobectomy (ATL)" 10/01/2002 - "The aim of this study was to assess the eligibility to drive in patients with mesial temporal sclerosis who undergo anterior temporal lobectomy" 07/01/2002 - "Further studies are ongoing to determine if these ERP abnormalities predict hippocampal sclerosis on histopathology, or outcome after anterior temporal lobectomy." 11/01/2005 - "The sample consisted of all patients with a primary diagnosis of mesial temporal sclerosis (MTS) who underwent anterior temporal lobectomy" 05/01/2005 - "Anterior temporal lobectomy with amygdalohippocampectomy was performed in both patients, and pathological examinations revealed hippocampal sclerosis" Get all the results and reference details, order at left...
50 Diseases and 289 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Amobarbital (Amsal)
2.	remifentanil (Ultiva)
3.	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
4.	Citric Acid (Citrate)
5.	N-Methylaspartate (NMDA)
6.	Prolactin
7.	Kainic Acid (Kainate)
8.	Fentanyl (Sublimaze)
9.	Enzymes
10.	Coenzyme A (CoA)
13 Drugs and Important Bio-Agents and 14 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Patient Readmission
2.	Electrodes (Electrode)
3.	Hemispherectomy
4.	Surgical Decompression
5.	Psychosurgery (Lobotomy)
10 Therapies and Procedures and 15 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>